Related Experiment Video
Updated: Apr 19, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Oncogenic STRAP functions as a novel negative regulator of E-cadherin and p21(Cip1) by modulating the transcription
1a Division of Hematology and Oncology; Department of Medicine; UAB Comprehensive Cancer Center; University of Alabama at Birmingham ; Birmingham , AL USA.
Abstract:
We have previously reported the identification of a novel WD-domain protein, STRAP that plays a role in maintenance of mesenchymal morphology by regulating E-cadherin and that enhances tumorigenicity partly by downregulating CDK inhibitor p21(Cip1). However, the functional mechanism of regulation of E-cadherin and p21(Cip1) by STRAP is unknown. Here, we have employed STRAP knock out and knockdown cell models (mouse embryonic fibroblast, human cancer cell lines) to show how STRAP downregulates E-cadherin and p21(Cip1) by abrogating the binding of Sp1 to its consensus binding sites. Moreover, ChIP assays suggest that STRAP recruits HDAC1 to Sp1 binding sites in p21(Cip1) promoter. Interestingly, loss of STRAP can stabilize Sp1 by repressing its ubiquitination in G1 phase, resulting in an enhanced expression of p21(Cip1) by >4.5-fold and cell cycle arrest. Using Bioinformatics and Microarray analyses, we have observed that 87% mouse genes downregulated by STRAP have conserved Sp1 binding sites. In NSCLC, the expression levels of STRAP inversely correlated with that of Sp1 (60%). These results suggest a novel mechanism of regulation of E-cadherin and p21(Cip1) by STRAP by modulating Sp1-dependent transcription, and higher expression of STRAP in lung cancer may contribute to downregulation of E-cadherin and p21(Cip1) and to tumor progression.
Insights
STRAP protein downregulates E-cadherin and p21(Cip1) by inhibiting Sp1 transcription. Loss of STRAP stabilizes Sp1, increasing p21(Cip1) and arresting cell cycle, suggesting STRAP
Area of Science:
- Molecular and Cellular Biology
- Cancer Biology
- Epigenetics
Background:
- STRAP (STRA6-interacting protein) is a novel WD-domain protein.
- STRAP influences mesenchymal morphology, E-cadherin regulation, and tumorigenicity.
- The precise mechanism by which STRAP regulates E-cadherin and p21(Cip1) remains unclear.
Purpose of the Study:
- To elucidate the functional mechanism of STRAP in regulating E-cadherin and p21(Cip1).
- To investigate STRAP's role in Sp1-dependent transcription and its implications in cancer.
Main Methods:
- Utilized STRAP knockout and knockdown cell models (mouse embryonic fibroblast, human cancer cell lines).
- Performed Chromatin Immunoprecipitation (ChIP) assays.
- Conducted Bioinformatics and Microarray analyses.
- Analyzed Sp1 binding and ubiquitination.
- Correlated STRAP and Sp1 expression in Non-Small Cell Lung Cancer (NSCLC).
Main Results:
- STRAP downregulates E-cadherin and p21(Cip1) by abrogating Sp1 binding to consensus sites.
- STRAP recruits HDAC1 to Sp1 binding sites in the p21(Cip1) promoter.
- Loss of STRAP stabilizes Sp1 by inhibiting ubiquitination, leading to >4.5-fold p21(Cip1) increase and cell cycle arrest.
- 87% of STRAP-downregulated mouse genes possess conserved Sp1 binding sites.
- STRAP expression inversely correlates with Sp1 levels in 60% of NSCLC cases.
Conclusions:
- STRAP regulates E-cadherin and p21(Cip1) via a novel mechanism involving Sp1-dependent transcription modulation.
- Elevated STRAP expression in lung cancer may promote tumor progression by downregulating E-cadherin and p21(Cip1).
- STRAP represents a potential therapeutic target in lung cancer.
Related Concept Videos
Negative Regulator Molecules
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Anaphase Promoting Complex
Positive Regulator Molecules

